Advertisement
UK markets closed

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     

  • CRUDE OIL

    83.68
    +0.87 (+1.05%)
     

  • GOLD FUTURES

    2,345.80
    +7.40 (+0.32%)
     

  • DOW

    38,044.57
    -416.35 (-1.08%)
     

  • Bitcoin GBP

    51,701.79
    +471.67 (+0.92%)
     

  • CMC Crypto 200

    1,392.88
    +10.31 (+0.75%)
     

  • NASDAQ Composite

    15,587.63
    -125.12 (-0.80%)
     

  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     
Stocks:

Trending tickers

Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

Vantex Modifies Stock Option Plan

Marketwired

LA PRAIRIE, QUEBEC--(Marketwired - Mar 4, 2015) - Vantex (TSX VENTURE:VAX)(UD7A.F)(VAX.V) board of directors approved modifications to the Company's Stock Option Plan. The new Plan will now reserve 8,000,000 common shares of the Company for option purposes, compared to 6,290,000 shares for the previous Plan. The options are available for officers, directors, employees and consultants of the Company and account for less than 10 % of the Company's outstanding shares. This modification is subject to the approval of the TSX Venture Exchange.

No new stock options were granted as part of this operation.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.